Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Autologous cell-based therapies, especially SVF, effectively and safely improve atrophic acne scars.

Upadacitinib improved multiple immune-related conditions in one patient.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Human placental extract effectively and safely improves melasma, ulcers, and alopecia areata.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Oral Apremilast effectively treats alopecia areata in most patients.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

VYC-12L effectively improves skin smoothness, reduces fine lines, and boosts hydration.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Hydrogels show promise for scarless wound healing by reducing skin fibrosis.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Stress can trigger or worsen alopecia areata.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Strainful life events may significantly trigger alopecia areata.